Table 1. Description of selected studies that met inclusion criteria for this review.

HA-MRSA: hospital-acquired methicillin-resistant Staphylococcus aureus; CA-MRSA: community-acquired methicillin-resistant Staphylococcus aureus; PVL: Panton-Valentine Leukocidin

Study	Location	Study Period	Samples	Conclusion
Huang, et al. [8]	United States	2003-2004	283 MRSA samples, 127 (45%) were of CA-MRSA origin	CA-MRSA has disseminated into hospital systems and has most likely cross-mixed with hospital strands
Kateete, et al. [9]	Uganda	2011 (February-October)	742; 140 of 742 were S. aureus. 42 of 140 were MRSA	HA-MRSA strands were found to exist in the general population amongst eastern Ugandan children
Peng, et al. [15]	China	2012-2017	835; 80% HA-MRA, 20% CA-MRSA	Both CA-MRSA & HA-MRSA were 100% resistant to Penicillin and Oxacillin treatments, as well as 100% susceptible to vancomycin, linezolid, and tigecycline. CA-MRSA showed 94% susceptibility to ciprofloxacin while HA-MRSA showed only 14% susceptibility to ciprofloxacin
Bhatta, et al. [18]	Nepal	2012-2106	400; 139 MRSA (90% of CA-MRSA were PVL+)	PVL was a sufficient method of distinguishing CA-MRSA from HA-MRSA